Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis

被引:57
|
作者
Howes, Oliver D. [1 ,2 ,3 ,4 ]
Hird, Emily J. [1 ,2 ]
Adams, Rick A. [5 ,6 ]
Corlett, Philip R. [7 ]
McGuire, Philip [1 ,2 ]
机构
[1] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England
[2] South London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England
[3] Hammersmith Hosp, Med Res Council, London Inst Med Sci, London, England
[4] Imperial Coll London, Inst Clin Sci, Fac Med, London, England
[5] UCL, Dept Comp Sci, Ctr Med Image Comp, London, England
[6] Max Planck Univ Coll London, Ctr Computat Psychiat & Ageing Res, London, England
[7] Yale Sch Med, Dept Psychiat, New Haven, CT USA
基金
英国工程与自然科学研究理事会; 英国惠康基金; 英国医学研究理事会;
关键词
Computational psychiatry; Imaging; Prodrome; Psychosis; Risk; Schizophrenia; VENTRAL STRIATAL ACTIVATION; ULTRA-HIGH RISK; CORTISOL AWAKENING RESPONSE; PREDICTION-ERROR SIGNAL; REWARD PREDICTION; SCHIZOPHRENIA-PATIENTS; SYNTHESIS CAPACITY; PRODROMAL SIGNS; BASE-LINE; STRESS;
D O I
10.1016/j.biopsych.2020.03.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aberrant salience hypothesis proposes that striatal dopamine dysregulation causes misattribution of salience to irrelevant stimuli leading to psychosis. Recently, new lines of preclinical evidence on information coding by subcortical dopamine coupled with computational models of the brain's ability to predict and make inferences about the world (predictive processing) provide a new perspective on this hypothesis. We review these and summarize the evidence for dopamine dysfunction, reward processing, and salience abnormalities in people at clinical high risk of psychosis (CHR) relative to findings in patients with psychosis. This review identifies consistent evidence for dys-regulated subcortical dopamine function in people at CHR, but also indicates a number of areas where neurobio-logical processes are different in CHR subjects relative to patients with psychosis, particularly in reward processing. We then consider how predictive processing models may explain psychotic symptoms in terms of alterations in prediction error and precision signaling using Bayesian approaches. We also review the potential role of environ-mental risk factors, particularly early adverse life experiences, in influencing the prior expectations that individuals have about their world in terms of computational models of the progression from being at CHR to frank psychosis. We identify a number of key outstanding questions, including the relative roles of prediction error or precision signaling in the development of symptoms and the mechanism underlying dopamine dysfunction. Finally, we discuss how the integration of computational psychiatry with biological investigation may inform the treatment for people at CHR of psychosis.
引用
收藏
页码:304 / 314
页数:11
相关论文
共 50 条
  • [21] Aberrant Salience Is Related to Dysfunctional Self-Referential Processing in Psychosis
    Pankow, Anne
    Katthagen, Teresa
    Diner, Sarah
    Deserno, Lorenz
    Boehme, Rebecca
    Kathmann, Nobert
    Gleich, Tobias
    Gaebler, Michael
    Walter, Henrik
    Heinz, Andreas
    Schlagenhauf, Florian
    SCHIZOPHRENIA BULLETIN, 2016, 42 (01) : 67 - 76
  • [22] Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
    Catalan, Ana
    Tognin, Stefania
    Kempton, Matthew J.
    Stahl, Daniel
    Salazar de Pablo, Gonzalo
    Nelson, Barnaby
    Pantelis, Christos
    Riecher-Rossler, Anita
    Bressan, Rodrigo
    Barrantes-Vidal, Neus
    Krebs, Marie-Odile
    Nordentoft, Merete
    Ruhrmann, Stephan
    Sachs, Gabriele
    Rutten, Bart P. F.
    van Os, Jim
    de Haan, Lieuwe
    van der Gaag, Mark
    Valmaggia, Lucia R.
    McGuire, Philip
    PSYCHOLOGICAL MEDICINE, 2022, 52 (08) : 1569 - 1577
  • [23] Prediction and Prevention of Psychosis in Youth at Clinical High Risk
    Addington, Jean
    Heinssen, Robert
    ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 8, 2012, 8 : 269 - +
  • [24] Predictors of Transition to Psychosis in Individuals at Clinical High Risk
    Addington, Jean
    Farris, Megan
    Stowkowy, Jacqueline
    Santesteban-Echarri, Olga
    Metzak, Paul
    Kalathil, Mohammed Shakeel
    CURRENT PSYCHIATRY REPORTS, 2019, 21 (06)
  • [25] Treating young individuals at clinical high risk for psychosis
    Marshall, Catherine
    Addington, Jean
    Epstein, Irvin
    Liu, Lu
    Deighton, Stephanie
    Zipursky, Robert B.
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 (01) : 60 - 68
  • [26] Disability in people clinically at high risk of psychosis
    Velthorst, Eva
    Nieman, Darien H.
    Linszen, Don
    Becker, Hiske
    de Haan, Lieuwe
    Dingemans, Peter M.
    Birchwood, Max
    Patterson, Paul
    Salokangas, Raimo K. R.
    Heinimaa, Markus
    Heinz, Andreas
    Juckel, Georg
    von Reventlow, Heinrich Graf
    French, Paul
    Stevens, Helen
    Schultze-Lutter, Frauke
    Klosterkoetter, Joachim
    Ruhrmann, Stephan
    BRITISH JOURNAL OF PSYCHIATRY, 2010, 197 (04) : 278 - 284
  • [27] Sleep Disturbance in Individuals at Clinical High Risk for Psychosis
    Zaks, Nina
    Velikonja, Tjasa
    Parvaz, Muhammad A.
    Zinberg, Jamie
    Done, Monica
    Mathalon, Daniel H.
    Addington, Jean
    Cadenhead, Kristin
    Cannon, Tyrone
    Cornblatt, Barbara
    McGlashan, Thomas
    Perkins, Diana
    Stone, William S.
    Tsuang, Ming
    Walker, Elaine
    Woods, Scott W.
    Keshavan, Matcheri S.
    Buysse, Daniel J.
    Velthorst, Eva
    Bearden, Carrie E.
    SCHIZOPHRENIA BULLETIN, 2022, 48 (01) : 111 - 121
  • [28] Theory of Mind in patients at clinical high risk for psychosis
    Stanford, Arielle D.
    Messinger, Julie
    Malaspina, Dolores
    Corcoran, Cheryl M.
    SCHIZOPHRENIA RESEARCH, 2011, 131 (1-3) : 11 - 17
  • [29] Neurocognition in Kenyan youth at clinical high risk for psychosis
    Mamah, Daniel
    Mutiso, Victoria N.
    Ndetei, David M.
    SCHIZOPHRENIA RESEARCH-COGNITION, 2021, 25
  • [30] Neurochemical effects of oxytocin in people at clinical high risk for psychosis
    Davies, Cathy
    Rutigliano, Grazia
    De Micheli, Andrea
    Stone, James M.
    Ramella-Cravaro, Valentina
    Provenzani, Umberto
    Cappucciati, Marco
    Scutt, Eleanor
    Paloyelis, Yannis
    Oliver, Dominic
    Murguia, Silvia
    Zelaya, Fernando
    Allen, Paul
    Shergill, Sukhi
    Morrison, Paul
    Williams, Steve
    Taylor, David
    Lythgoe, David J.
    McGuire, Philip
    Fusar-Poli, Paolo
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (05) : 601 - 615